VitaNova Life Sciences (VNOV) Cash from Operations Growth (3y) (2021 - 2026)
VitaNova Life Sciences (VNOV) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 0.95% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 28.59% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 10.23% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -77.50% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -32.31% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 1.26% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -22.47% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 44.80% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -47.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -47.48% |
| Oct 31, 2025 | 242.22% |
| Jul 31, 2025 | 238.84% |
| Apr 30, 2025 | 232.14% |
| Jan 31, 2025 | 241.56% |
| Oct 31, 2024 | -23.53% |
| Jul 31, 2024 | -317.17% |
| Jan 31, 2024 | -134.24% |
| Oct 31, 2023 | 36.06% |
| Apr 30, 2023 | 46.35% |
| Jan 31, 2023 | -57.48% |
| Oct 31, 2022 | 34.89% |
| Jul 31, 2022 | 32.78% |
| Apr 30, 2022 | -0.45% |
| Jan 31, 2022 | 28.92% |
| Oct 31, 2021 | 17.60% |
| Jul 31, 2021 | 13.75% |